Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival.
Semyon YakushovMaxim E MenyailoEvgeniy V DenisovIrina KarlinaViktoria ZainullinaKirill KirgizovOlga RomantsovaPeter TimashevIlya V UlasovPublished in: Cancers (2022)
Collectively, our results identify a novel role of cellular proteins in contributing to tumor cell resistance and escape from doxorubicin therapy and contributing to ES progression.